The cholesterol emboli syndrome in atherosclerosis

Related Experiment Video

Updated: May 14, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Adriana Quinones1, Muhamed Saric

  • 1Leon H. Charney Division of Cardiology, New York University Langone Medical Center, 560 First Avenue, New York, NY 10016, USA. Adriana.Quinones@nyumc.org

Current Atherosclerosis Reports
|February 21, 2013
PubMed

Insights

Cholesterol emboli syndrome, a complication of atherosclerosis, occurs when cholesterol crystals block small arteries, causing organ damage. Management focuses on risk factor modification and supportive care, as no specific cure exists.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology

Background:

  • Cholesterol emboli syndrome (CES) is a rare but severe complication of atherosclerotic disease.
  • It involves the embolization of cholesterol crystals and atheroma debris from the aorta to smaller arteries.

Purpose of the Study:

  • To describe the pathophysiology, clinical manifestations, and current management strategies for cholesterol emboli syndrome.

Main Methods:

  • Literature review of atherosclerotic disease complications.
  • Analysis of clinical presentations and diagnostic findings in CES.
  • Evaluation of treatment outcomes for supportive and interventional measures.

Main Results:

  • CES leads to end-organ damage via arterial occlusion and inflammation.
  • Common manifestations include renal failure, blue toe syndrome, and neurological deficits.
  • No specific therapy exists; management is supportive.

Conclusions:

  • Cholesterol emboli syndrome requires prompt recognition and supportive care.
  • Risk factor modification, statins, and antiplatelet agents are key.
  • Anticoagulation and thrombolysis should be avoided; surgical/endovascular exclusion of the source may be necessary.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...